首页> 外文期刊>The journal of asthma >Effects of IFN-gamma on cell growth and the expression of ADAM33 gene in human embryonic lung Mrc-5 fibroblasts in vitro
【24h】

Effects of IFN-gamma on cell growth and the expression of ADAM33 gene in human embryonic lung Mrc-5 fibroblasts in vitro

机译:IFN-GAMMA对体外人胚肺MRC-5成纤维细胞ADAM33基因表达的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To investigate the effects of interferon-gamma (IFN-gamma) on the proliferation and viability of human embryonic lung Mrc-5 fibroblasts in vitro and the expression of the A Disintegrin and Metalloprotease 33 (ADAM33) gene and to explore the mechanism of airway remodeling. Methods: Mrc-5 fibroblasts were sensitized with Dermatophagoides farinae 1 (Derf1) in vitro to mimic in vivo conditions observed in bronchial asthma. An inverted fluorescence microscope was used to observe changes in cell morphology before and after treatment. The viability of Mrc-5 cells was tested using the Cell Counting kit-8 (CCK8). Expression of the ADAM33 gene and protein in Mrc-5 cells was assessed using qPCR and Western blotting, respectively. Results: Different concentrations of Derf1 increased cell growth and the expression of the ADAM33 gene in Mrc-5 cells, and these changes were most obvious in the 10 mu g/ml group. In contrast, IFN-gamma decreased cell growth and the expression of the ADAM33 gene in both Mrc-5 cells and Derf1-induced Mrc-5 cells, and these changes were most obvious in the 10 ng/ml group. The negative effects of 10 ng/ml IFN-gamma were the most significant at 32 hours. Conclusions: Derf1-induced Mrc-5 cells successfully imitated the in vivo conditions observed in patients with asthma. IFN-gamma inhibited the proliferation and viability of Mrc-5 cells, and Derf1-induced Mrc-5 cells were more sensitive to IFN-gamma treatment. IFN-gamma treatment significantly downregulated the expression of the ADAM33 gene in a concentration- and time-dependent manner. IFN-gamma may participate in airway remodeling in asthma by regulating the expression of the ADAM33 gene.
机译:目的:探讨干扰素 - γ(IFN-Gamma)对体外胚胎肺MRC-5成纤维细胞的增殖和活力的影响及解肢体和金属蛋白酶33(ADAM33)基因的表达及探索机制气道重塑。方法:将MRC-5成纤维细胞用皮肤病患者致敏感,体外敏化,以模拟在支气管哮喘中观察到的体内病症。倒荧光显微镜用于观察治疗前后细胞形态的变化。使用细胞计数试剂盒-8(CCK8)测试MRC-5细胞的活力。使用QPCR和Western印迹评估ADAM33基因和蛋白质在MRC-5细胞中的表达。结果:不同浓度的Derf1增加细胞生长和MRC-5细胞中的ADAM33基因的表达,并且这些变化在10μg/ ml基团中最明显。相反,IFN-GAMMA在MRC-5细胞和DERF1诱导的MRC-5细胞中降低细胞生长和ADAM33基因的表达,并且这些变化在10ng / mL基团中最明显。 10ng / ml IFN-gamma的负面影响在32小时内最显着。结论:Derf1诱导的MRC-5细胞成功模仿哮喘患者观察到的体内病症。 IFN-Gamma抑制MRC-5细胞的增殖和活力,并且Derf1诱导的MRC-5细胞对IFN-Gamma治疗更敏感。 IFN-Gamma治疗以浓度和时间依赖的方式显着下调了ADAM33基因的表达。 IFN-Gamma可以通过调节ADAM33基因的表达来参与哮喘中的气道重塑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号